The authors further examined the effects of PLEKHG4 on cell proliferation, migration, invasion, and epithelial–mesenchymal transition (EMT) by overexpressing or knocking down PLEKHG4 in thyroid cancer cells. The gene discussed is PLEKHG4; the disease is thyroid cancer.